Effects of IQP, VEP and Spirulina platensis hydrolysates on the local kidney renin angiotensin system in spontaneously hypertensive rats

Zheng,Jiahui; Wang,Jingyue; Pan,Huanglei; Wu,Hongli; Ren,Difeng; Lu,Jun

doi:10.3892/mmr.2017.7602

Effects of IQP, VEP and Spirulina platensis hydrolysates on the local kidney renin angiotensin system in spontaneously hypertensive rats

Authors:
- Jiahui Zheng
- Jingyue Wang
- Huanglei Pan
- Hongli Wu
- Difeng Ren
- Jun Lu
View Affiliations

Affiliations: Beijing Key Laboratory of Forest Food Process and Safety, College of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, P.R. China, Beijing Engineering Research Center of Protein and Functional Peptides, China National Research Institute of Food and Fermentation Industries, Beijing 100015, P.R. China
Published online on: September 25, 2017 https://doi.org/10.3892/mmr.2017.7602
Pages: 8485-8492

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the antihypertensive effects of the bioactive Spirulina platensis peptides Ile‑Gln‑Pro (IQP), Val‑Glu‑Pro (VEP), as well as Spirulina platensis hydrolysates (SH), and assessed whether the synthesis of components of the myocardial and renal local renin angiotensin system (RAS) are regulated differentially in spontaneously hypertensive rats (SHR). The SHR were administrated with IQP, VEP and SH respectively (10 mg/kg/day) for 6 weeks and received continuous monitoring of blood pressure (BP) for two more weeks. During the trial, the rats' kidney tissues were removed from these rats and collected at weeks 3, 6 and 8. The expression of the main components of local kidney RAS was measured at the mRNA levels by reverse transcription‑quantitative polymerase chain reaction, and at the protein levels by ELISA or western blotting. Oral administration of IQP, VEP and SH into SHR resulted in marked antihypertensive effects. IQP, VEP and SH decreased rats' BP by affecting the expression of local kidney RAS components via downregulating the angiotensin‑converting enzyme (ACE), Ang II and angiotensin II (Ang II) and angiotensin type‑1 receptor (AT 1), while upregulating ACE2, Ang (1‑7), Mas and AT 2. The comparisons of SH effects on local tissue RAS demonstrated that local kidney RAS regulated BP via the ACE‑Ang II‑AT 1/AT 2 axis and the ACE2‑Ang (1‑7)‑Mas axis primarily at the mRNA level, while the local myocardium RAS mainly at the protein level. This preliminary study suggests that the main components of local RAS presented different expression levels in myocardium and kidney, which is important to the development of bioactive peptides targeting for lowering BP by changing the levels of some components in local RAS in specific tissues.

View Figures

View References

1	World Health Organization (WHO), . A global brief on hypertension. http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdfApril 3–2013
2	Varagic J, Ahmad S, Nagata S and Ferrario CM: ACE2: Angiotensin II/angiotensin-(1–7) balance in cardiac and renal injury. Curr Hypertens Rep. 16:4202014. View Article : Google Scholar : PubMed/NCBI
3	Iwai M and Horiuchi M: Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT 1 axis vs. ACE2-angiotensin-(1–7)-Mas receptor axis. Hypertens Res. 32:533–536. 2009. View Article : Google Scholar : PubMed/NCBI
4	Samuel P, Ali Q, Sabuhi R, Wu Y and Hussain T: High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats. Am J Physiol Renal Physiol. 303:F412–F419. 2012. View Article : Google Scholar : PubMed/NCBI
5	Kobori H, Nangaku M, Navar LG and Nishiyama A: The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 59:251–287. 2007. View Article : Google Scholar : PubMed/NCBI
6	Ozkayar N, Dede F, Akyel F, Yildirim T, Ateş I, Turhan T and Altun B: Relationship between blood pressure variability and renal activity of the renin-angiotensin system. J Hum Hypertens. 30:297–302. 2016. View Article : Google Scholar : PubMed/NCBI
7	Nguyen Dinh Cat A and Touyz RM: A new look at the renin-angiotensin system-focusing on the vascular system. Peptides. 32:2141–2150. 2011. View Article : Google Scholar : PubMed/NCBI
8	Velez JC: The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol. 5:89–100. 2009. View Article : Google Scholar : PubMed/NCBI
9	Carey RM: The intrarenal renin-angiotensin system in hypertension. Adv Chronic Kidney Dis. 22:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
10	Ferrão FM, Lara LS and Lowe J: Renin-angiotensin system in the kidney: What is new? World J Nephrol. 3:64–76. 2014. View Article : Google Scholar : PubMed/NCBI
11	Giani JF, Shah KH, Khan Z, Bernstein EA, Shen XZ, McDonough AA, Gonzalez-Villalobos RA and Bernstein KE: The intrarenal generation of angiotensin II is required for experimental hypertension. Curr Opin Pharmacol. 21:73–81. 2015. View Article : Google Scholar : PubMed/NCBI
12	Naito Y, Tsujino T, Fujioka Y, Ohyanagi M and Iwasaki T: Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension. 40:827–833. 2002. View Article : Google Scholar : PubMed/NCBI
13	Re RN: The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol. 16:317–327. 2001. View Article : Google Scholar : PubMed/NCBI
14	Paul M, Mehr A Poyan and Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev. 86:747–803. 2006. View Article : Google Scholar : PubMed/NCBI
15	Fedoseeva LA, Riazanova MA, Antonov EV, Dymshits GM and Markel' AL: Renin-angiotensin system gene expression in the kidney and in the heart in hypertensive ISIAH rats. Biomed Khim. 57:410–419. 2011.(In Russian). View Article : Google Scholar : PubMed/NCBI
16	Pan H, She X, Wu H, Ma J, Ren D and Lu J: Long-term regulation of the local renin-angiotensin system in the myocardium of spontaneously hypertensive rats by feeding bioactive peptides derived from spirulina platensis. J Agric Food Chem. 63:7765–7774. 2015. View Article : Google Scholar : PubMed/NCBI
17	Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH and Du K: Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension. 44:907–912. 2004. View Article : Google Scholar : PubMed/NCBI
18	Malikova E, Galkova K, Vavrinec P, Vavrincova-Yaghi D, Kmecova Z, Krenek P and Klimas J: Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat. Mol Cell Biochem. 418:147–157. 2016. View Article : Google Scholar : PubMed/NCBI
19	Lu J, Ren DF, Xue YL, Sawano Y, Miyakawa T and Tanokura M: Isolation of an antihypertensive peptide from alcalase digest of spirulina platensis. J Agric Food Chem. 58:7166–7171. 2010. View Article : Google Scholar : PubMed/NCBI
20	Lu J, Ren DF, Wang JZ and Tanokura M: Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from Spirulina platensis. Prog Biochem Biophys. 37:568–574. 2010. View Article : Google Scholar
21	Buñag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 34:279–282. 1973.PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Siragy HM: AT(1) and AT(2) receptors in the kidney: Role in disease and treatment. Am J Kidney Dis. 36(3 Suppl 1): S4–S9. 2000. View Article : Google Scholar : PubMed/NCBI
24	Marczak ED, Usui H, Fujita H, Yang Y, Yokoo M, Lipkowski AW and Yoshikawa M: New antihypertensive peptides isolated from rapeseed. Peptides. 24:791–798. 2003. View Article : Google Scholar : PubMed/NCBI
25	Igarashi K, Yoshioka K, Mizutani K, Miyakoshi M, Murakami T and Akizawa T: Blood pressure-depressing activity of a peptide derived from silkworm fibroin in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 70:517–520. 2006. View Article : Google Scholar : PubMed/NCBI
26	Lu J, Sawano Y, Miyakawa T, Xue YL, Cai MY, Egashira Y, Ren DF and Tanokura M: One-week antihypertensive effect of Ile-Gln-Pro in spontaneously hypertensive rats. J Agric Food Chem. 59:559–563. 2011. View Article : Google Scholar : PubMed/NCBI
27	Lu J, Yang Y, Chen L, Ren DF, Cai MY, Wang JZ, Egashira Y and Tanokura M: In vivo antihypertensive effect of Val-Glu-Pro in spontaneously hypertensive rats. Prog Biochem Biophys. 38:353–360. 2011. View Article : Google Scholar
28	Majumder K, Chakrabarti S, Morton JS, Panahi S, Kaufman S, Davidge ST and Wu J: Egg-derived tri-peptide IRW exerts antihypert effects in spontaneously hypertensive rats. PLoS One. 8:e828292013. View Article : Google Scholar : PubMed/NCBI
29	Bader M and Ganten D: Update on tissue renin-angiotensin systems. J Mol Med (Berl). 86:615–621. 2008. View Article : Google Scholar : PubMed/NCBI
30	Carey RM, Jin XH and Siragy HM: Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens. 14:98S–102S. 2001. View Article : Google Scholar : PubMed/NCBI
31	Yu Z, Yin Y, Zhao W, Chen F and Liu J: Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the renin-angiotensin system. J Agric Food Chem. 62:912–917. 2014. View Article : Google Scholar : PubMed/NCBI
32	Červenka L, Bíbová J, Husková Z, Vaňourková Z, Kramer HJ, Herget J, Jíchová Š, Sadowski J and Hampl V: Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1–7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia. Physiol Res. 64:11–24. 2015.PubMed/NCBI
33	Mizuiri S and Ohashi Y: ACE and ACE2 in kidney disease. World J Nephrol. 4:74–82. 2015. View Article : Google Scholar : PubMed/NCBI
34	Soler MJ, Wysocki J and Batlle D: ACE2 alterations in kidney disease. Nephrol Dial Transpl. 28:2687–2697. 2013. View Article : Google Scholar
35	Kuba K, Imai Y and Penninger JM: Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ J. 77:301–308. 2013. View Article : Google Scholar : PubMed/NCBI
36	De Mello WC and Frohlich ED: On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides. 32:1774–1779. 2011. View Article : Google Scholar : PubMed/NCBI
37	Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ and Oudit GY: Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS. J Mol Cell Cardiol. 66:167–176. 2014. View Article : Google Scholar : PubMed/NCBI
38	Patel KP and Schultz HD: Angiotensin peptides and nitric oxide in cardiovascular disease. Antioxid Redox Sign. 19:1121–1132. 2013. View Article : Google Scholar
39	Wolf G and Ritz E: Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications. Kidney Int. 67:799–812. 2005. View Article : Google Scholar : PubMed/NCBI